Skip to main content

nl
fr
en

Other official information and services: www.belgium.be

Your medicine and health products

About the FAMHP
Jobs
Publications
Press
Contact
Complaints
Webportal

Home
Human medicines
Veterinary medicines
Information for the public
Notification of adverse reactions or incidents

Home
Human medicines
Health Products
Medical devices and their accessories
Materiovigilance

Materiovigilance

What shall be notified?

Who should notify?

When must incidents be notified?

How should incidents be notified?

Last updated on 20/05/2009

Notification of adverse reactions or incidents

PIL and SPC
of a medicine

(PIL: patient information leaflet SPC: summary of product characteristics)

News

22/05/2019

New way of paying the FAMPHP: invoices replace advance payments

14/05/2019

Brexit: specific information for sponsors of clinical trials

13/05/2019

Medicines for veterinary use: new Belgian rules from 1 May 2019 for the harmonisation of SPC, labelling and patient information leaflet

10/05/2019

New measures to limit unavailability of medicines

All news

© 2016 - FAMHP

Site map
Disclaimer
Complaints
Contact